MedPath

MARINUS PHARMACEUTICALS INC

MARINUS PHARMACEUTICALS INC logo
🇺🇸United States
Ownership
Public
Established
2003-01-01
Employees
165
Market Cap
-
Website
http://www.marinuspharma.com

Clinical Trials

14

Active:13
Completed:1

Trial Phases

2 Phases

Phase 1:11
Phase 3:1

Drug Approvals

2

NMPA:1
FDA:1

Drug Approvals

Ganaxolone Oral Suspension

Product Name
泽元安
Approval Number
国药准字HJ20240071
Approval Date
Jul 9, 2024
NMPA

Clinical Trials

Distribution across different clinical trial phases (12 trials with phase data)• Click on a phase to view related trials

Phase 1
11 (91.7%)
Phase 3
1 (8.3%)
No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.